Hepatic zonation determines tumorigenic potential of mutant β-catenin

Nature. doi: 10.1038/s41586-025-09733-1

Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signaling

Nature Genetics. doi: 10.1038/s41588-025-02496-5

Metabolic dysfunction-associated steatotic liver disease and steatohepatitis-associated hepatocarcinoma preclinical models

Nature Reviews Gastroenterology & Hepatology. doi: 10.1038/s41575-025-01162-9

Understanding liver and digestive diseases: a paved road to improve diagnosis, management, and treatment 

Exploration of Digestive Diseases. doi: 10.37349/edd.2026.1005110

Improving surgical treatments for hepatocellular carcinoma

Nature Reviews Gastroenterology and Hepatology. doi: 10.1038/s41575-025-01143-y

Nrf2-mediated metabolic reprogramming drives regulatory T cell accumulation in hepatocellular carcinoma

Nature Communications. doi: 10.1038/s41467-026-73485-3

Strategies to address non-proportional hazards between survival curves - Lessons from phase III trials in hepatocellular carcinoma

Journal of Hepatology. doi: 10.1016/j.jhep.2025.08.042

Mutational scanning reveals oncogenic CTNNB1 mutations have diverse effects on signaling

Nature Genetics. doi: 10.1038/s41588-025-02496-5

Activated ATF6α is a hepatic tumour driver restricting immunosurveillance

Nature. doi: 10.1038/s41586-025-10036-8